News

• Management and Business
• Research and Development

Nippon Shokubai Announces Signing of License Agreement with Rena Therapeutics Inc. 　–to Start Heteroduplex Oligonucleotide (HDO) Synthesis Service for Pharmaceutical Companies and Academia Both Within and Outside Japan–

• Sustainability
• Research and Development

NEDO Adopts Nippon Shokubai and Tokuyama Project to Develop Large Alkaline Water Electrolyzers and Separators Suited to High-pressure Electrolysis

• Sustainability
• Research and Development

Nippon Shokubai participates in COI-NEXT led by the University of Tokyo to jointly develop an integrated agro-industrial GX technologies to contribute to increase food production and green chemical manufacturing

• Research and Development

Completion of the Clinical Research on Knee Osteoarthritis using “MicoCell™” 3D Cell Culture Vessel -Safety of Cell Aggregates Confirmed at our Collaborative Research Clinic-

• Research and Development

Participation in the Innovative Next Generation of Oligonucleotide Therapeutics Project conducted by AMED

• Research and Development

Development of a Coating Material with High Antiviral Effect! – The Inactivation of Human Coronavirus through the New Coating Material –